Department of Psychiatry, Geisel School of Medicine, Dartmouth College, New Hampshire.
Department of Psychiatry, University of Missouri, Columbia, Missouri.
J Clin Sleep Med. 2018 Nov 15;14(11):1911-1919. doi: 10.5664/jcsm.7492.
Individuals with primary insomnia often have poorer self-reported sleep than objectively measured sleep, a phenomenon termed negative sleep discrepancy. Recent studies suggest that this phenomenon might differ depending on comorbidities. This study examined sleep discrepancy, its night-to-night variability, and its correlates in comorbid insomnia and fibromyalgia.
Sleep diaries and actigraphy data were obtained from 223 adults with fibromyalgia and insomnia (age = 51.53 [standard deviation = 11.90] years; 93% women) for 14 days. Sleep discrepancy was calculated by subtracting diary from actigraphy estimates of sleep onset latency (SOL-D), wake after sleep onset (WASO-D), and total sleep time (TST-D) for each night. Night-to-night variability in sleep discrepancy was calculated by taking the within-individual standard deviations over 14 days. Participants completed measures of mood, pain, fatigue, sleep/pain medications, nap duration, and caffeine consumption.
Average sleep discrepancies across 14 days were small for all sleep parameters (< 10 minutes). There was no consistent positive or negative discrepancy. However, sleep discrepancy for any single night was large, with average absolute discrepancies greater than 30 minutes for all sleep parameters. Greater morning pain was associated with larger previous-night WASO-D, although diary and actigraphy estimates of WASO remained fairly concordant. Taking prescribed pain medications, primarily opioids, was associated with greater night-to-night variability in WASO-D and TST-D.
Unlike patients with primary insomnia, patients with comorbid fibromyalgia do not exhibit consistent negative sleep discrepancy; however, there are both substantial positive and negative discrepancies in all sleep parameters at the daily level. Future research is needed to investigate the clinical significance and implications of high night-to-night variability of sleep discrepancy, and the role of prescribed opioid medications in sleep perception.
原发性失眠患者的自我报告睡眠往往不如客观测量的睡眠差,这种现象称为负性睡眠差异。最近的研究表明,这种现象可能因合并症而异。本研究检查了合并性失眠和纤维肌痛患者的睡眠差异、其夜间变异性及其相关性。
从 223 名患有纤维肌痛和失眠的成年人(年龄=51.53[标准差=11.90]岁;93%为女性)中获得了 14 天的睡眠日记和活动记录仪数据。通过从活动记录仪估计的睡眠潜伏期(SOL-D)、睡眠后觉醒(WASO-D)和总睡眠时间(TST-D)中减去日记值来计算睡眠差异。通过在 14 天内计算个体内的标准偏差来计算睡眠差异的夜间变异性。参与者完成了情绪、疼痛、疲劳、睡眠/疼痛药物、小睡持续时间和咖啡因消耗的测量。
所有睡眠参数的 14 天平均睡眠差异均较小(<10 分钟)。没有一致的正或负差异。然而,任何单一夜间的睡眠差异都很大,所有睡眠参数的平均绝对差异大于 30 分钟。早晨疼痛越严重,前一晚的 WASO-D 越大,尽管日记和活动记录仪估计的 WASO 仍相当一致。服用规定的疼痛药物,主要是阿片类药物,与 WASO-D 和 TST-D 的夜间变异性增加有关。
与原发性失眠患者不同,患有合并性纤维肌痛的患者并没有表现出一致的负性睡眠差异;然而,在所有睡眠参数的日常水平上,都存在相当大的正性和负性差异。需要进一步研究来探讨睡眠差异夜间变异性高的临床意义和影响,以及规定的阿片类药物在睡眠感知中的作用。